Aeolus Pharmaceuticals, Inc. (OTCPK: AOLS)
Health Care · Pharmaceuticals · US
$—
— today · — 1Y
Aeolus Pharmaceuticals, Inc. (OTCPK: AOLS) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $152.00 and employs 4 people.
trading between 0.00 and 0.00.
Tweenvest scores Aeolus Pharmaceuticals, Inc. across four factors: quality 40/100, value 51/100, growth 0/100. Its strongest factor is value.
AOLS price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $152.00
- Revenue (TTM)
- $771.00K
- P/E
- —
- EPS
- -0.03
- Dividend yield
- —
- Beta (5Y)
- -64.36
- 52-week high
- $0.00
- 52-week low
- $0.00
- Avg volume (3M)
- —
- Shares outstanding
- 152.09M
- Employees
- 4
- Next earnings
- —
About Aeolus Pharmaceuticals, Inc.
Aeolus Pharmaceuticals, Inc. is a biopharmaceutical firm specializing in the development of innovative therapeutic compounds. Operating within the United States, the company's research pipeline addresses a diverse range of critical medical challenges, including biodefense, fibrotic conditions, oncology, infectious diseases, and central nervous system disorders. A core focus involves a distinct class of catalytic antioxidant compounds, which are being advanced as essential medical countermeasures against threats from nuclear, radiological, and chemical weapons, in addition to therapies for respiratory, neurological, and oncological ailments. Their flagship product candidate, AEOL 10150, has successfully navigated two Phase I clinical trials. This compound is being developed to combat the pulmonary complications associated with acute radiation syndrome, and also serves as a crucial protective agent against exposure to chemical vesicants and nerve agents. Further expanding its pipeline, Aeolus is also pursuing AEOL 11114B, AEOL 11203, and AEOL 11207 for the treatment of Parkinson's disease, alongside AEOL 20415, designed to address various infectious diseases. Established in 1994, Aeolus Pharmaceuticals is headquartered in Mission Viejo, California.
- ISIN
- US00765G1094
- Founded
- 1994
- Listed since
- Feb 2, 1996
- Exchange
- Pink Sheets LLC
- Currency
- USD
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Lucy Scientific Discovery Inc.OTCPK: LSDI.F | $176.00 | $— | — |
| Juva Life Inc.OTCPK: JUVA.F | $164.00 | $0.00 | — |
| Pure Global Cannabis Inc.OTCPK: PRCN.F | $164.00 | $0.00 | — |
| THC Biomed Intl Ltd.OTCPK: THCB.F | $164.00 | $0.00 | — |
| Halo Collective Inc.OTCPK: HCAN.F | $151.00 | $— | — |
| MPX International CorporationOTCPK: MPXO.F | $144.00 | $0.00 | — |
| Seelos Therapeutics, Inc.OTCPK: SEEL.Q | $136.00 | $— | — |
| Isodiol International Inc.OTCPK: ISOL.F | $129.00 | $0.00 | — |
Figures last refreshed Oct 4, 2026.